[Diffuse malignant peritoneal mesothelioma (DMPM) - a rare diagnosis]. 2020

Victoria Susanne Antonia Habbel, and Elisa Annabelle Mahler, and Bernd Feyerabend, and Karl-Jürgen Oldhafer, and Michael Josef Lipp
Asklepios Campus Hamburg, Medizinische Fakultät der Semmelweis Universität, Hamburg, Germany.

Diffuse malignant peritoneal mesothelioma (DMPM) is a rare diagnosis, found more frequently in men than in women. Symptoms are unspecific abdominal disorders making that diagnosis difficult to set. Causes of DMPM are yet to be discovered in entirety. Asbestos exposure is the reason for approximately 7 % of all peritoneal mesotheliomas. Until the evaluation of systematic cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) DMPM was a fatal diagnosis with a median overall survival (OS) of 4-13 months. The prognosis of DMPM dramatically improved with implementation of CRS and HIPEC to an OS of 30-92 month nowadys. CRS and HIPEC were performed in this case.

UI MeSH Term Description Entries
D006979 Hyperthermia, Induced Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation (heat waves, infra-red), ultrasound, or drugs. Fever Therapy,Hyperthermia, Local,Hyperthermia, Therapeutic,Thermotherapy,Induced Hyperthermia,Therapeutic Hyperthermia,Therapy, Fever,Local Hyperthermia
D008297 Male Males
D008654 Mesothelioma A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed) Mesotheliomas
D010534 Peritoneal Neoplasms Tumors or cancer of the PERITONEUM. Peritoneal Carcinomatosis,Peritoneal Surface Malignancy,Carcinomatosis, Peritoneal,Malignancy, Peritoneal Surface,Neoplasm, Peritoneal,Peritoneal Carcinomatoses,Peritoneal Neoplasm,Peritoneal Surface Malignancies,Surface Malignancy, Peritoneal
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy

Related Publications

Victoria Susanne Antonia Habbel, and Elisa Annabelle Mahler, and Bernd Feyerabend, and Karl-Jürgen Oldhafer, and Michael Josef Lipp
February 2014, Minerva chirurgica,
Victoria Susanne Antonia Habbel, and Elisa Annabelle Mahler, and Bernd Feyerabend, and Karl-Jürgen Oldhafer, and Michael Josef Lipp
January 1967, Rivista di anatomia patologica e di oncologia,
Victoria Susanne Antonia Habbel, and Elisa Annabelle Mahler, and Bernd Feyerabend, and Karl-Jürgen Oldhafer, and Michael Josef Lipp
November 2013, The Kaohsiung journal of medical sciences,
Victoria Susanne Antonia Habbel, and Elisa Annabelle Mahler, and Bernd Feyerabend, and Karl-Jürgen Oldhafer, and Michael Josef Lipp
January 1988, La Revue de medecine interne,
Victoria Susanne Antonia Habbel, and Elisa Annabelle Mahler, and Bernd Feyerabend, and Karl-Jürgen Oldhafer, and Michael Josef Lipp
January 2022, Frontiers in surgery,
Victoria Susanne Antonia Habbel, and Elisa Annabelle Mahler, and Bernd Feyerabend, and Karl-Jürgen Oldhafer, and Michael Josef Lipp
September 2019, Indian journal of surgical oncology,
Victoria Susanne Antonia Habbel, and Elisa Annabelle Mahler, and Bernd Feyerabend, and Karl-Jürgen Oldhafer, and Michael Josef Lipp
January 1993, Annales de radiologie,
Victoria Susanne Antonia Habbel, and Elisa Annabelle Mahler, and Bernd Feyerabend, and Karl-Jürgen Oldhafer, and Michael Josef Lipp
January 2019, Respiratory medicine case reports,
Victoria Susanne Antonia Habbel, and Elisa Annabelle Mahler, and Bernd Feyerabend, and Karl-Jürgen Oldhafer, and Michael Josef Lipp
December 2014, Ugeskrift for laeger,
Victoria Susanne Antonia Habbel, and Elisa Annabelle Mahler, and Bernd Feyerabend, and Karl-Jürgen Oldhafer, and Michael Josef Lipp
June 2004, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Copied contents to your clipboard!